The upregulated expression and raft targeting of annexin A2 and the cross-reactivity of anti-S2 antibodies to annexin A2 may contribute to the pathogenesis of SARS disease [232]. This evidence concerns the gene ANXA2 and severe acute respiratory syndrome.